Parameter | Total | One-stage surgery | Two-stage surgery |
---|---|---|---|
n (%) | n = 87 | n = 56 (64%) | n = 31 (36%) |
Female gender | 53 (61%) | 34 (61%) | 19 (61%) |
Age (years) [median (range)] | 49 (16–84) | 49.5 (20–84) | 48 (16–81) |
Tumor histopathology | |||
Papillary thyroid cancer | 73 (84%) | 48 (86%) | 25 (81%) |
Papillary microcarcinoma | 27 | 23 | 4 |
Follicular thyroid cancer | 14 (16%) | 8 (14%) | 6 (19%) |
Minimally invasive follicular thyroid cancer | 3 | 3 | 0 |
T stage | |||
pT1 | 49 (56%) | 36 (64%) | 13 (42%) |
pT2 | 16 (18%) | 7 (12%) | 9 (29%) |
pT3 | 17 (20%) | 11 (20%) | 6 (19%) |
pT4 | 5 (6%) | 2 (4%) | 3 (10%) |
Lymph node metastasis (pNpos)a | 21/55 (38%) | 12/26 (46%) | 9/29 (31%) |
Papillary thyroid cancer | 20 | 12 | 8 |
Follicular thyroid cancer | 1 | 0 | 1 |
Synchronous distant metastasis | 12 (14%) | 11 (20%) | 1 (3%) |
Lung | 8 | 8 | 0 |
Bone | 6 | 6 | 0 |
Liver | 1 | 1 | 0 |
Soft tissue | 3 | 2 | 1 |
Residual tumor (R+) | 7 (8%) | b | 5 (6%) |